C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C07K 14/045 (2006.01) C12N 9/12 (2006.01) C12N 15/11 (2006.01) C12Q 1/70 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2089666
Compositions and methods for modulating the effects of cytomegalovirus (CMV) infections are disclosed, comprising con- tacting CMV mRNA with an oligonucleotide or oligonucleotide analog which can bind with at least portions of the CMV RNA. In accordance with the preferred embodiments, oligonucleotides or oligonucleotide analogs are designed to bind with portions of the CMV mRNAs which code for the IE1, IE2 or DNA polymerase proteins. In accordance with a preferred embodiment, meth- ods of treatment of human cytomegalovirus are disclosed.
Anderson Kevin P.
Draper Kenneth G.
Borden Ladner Gervais Llp
Isis Pharmaceuticals Inc.
Isis Pharmaceuticals Inc.
LandOfFree
Oligonucleotides for modulating the effects of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for modulating the effects of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for modulating the effects of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1961495